Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 2 human prescription drug. By marketing category: BLA 2.
| Dosage form | NDCs |
|---|---|
| injection, solution | 2 |
| Route | NDCs |
|---|---|
| subcutaneous | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| genmab us, inc. | 2 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| EPKINLY | epcoritamab-bysp | injection, solution, subcutaneous | 82705-002BLA |
| EPKINLY | epcoritamab-bysp | injection, solution, subcutaneous | 82705-010BLA |
Compare
Other companies listing epcoritamab-bysp
- Rentschler Biopharma SE2 sites · 8 NDC
Enquiry
Common questions
- Is Genmab US, Inc. FDA approved?
- Genmab US, Inc. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Genmab US, Inc. make?
- 2 products are listed under Genmab US, Inc. in the openFDA NDC Directory, most often as injection, solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.